文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于药物输送和疗效测试的 3D 微工程化血管化肿瘤球体。

3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing.

机构信息

Department of Mechanical and Aerospace Engineering, Seoul National University, Seoul 08826, Republic of Korea; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.

Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea.

出版信息

Acta Biomater. 2023 Jul 15;165:153-167. doi: 10.1016/j.actbio.2022.10.009. Epub 2022 Oct 13.


DOI:10.1016/j.actbio.2022.10.009
PMID:36243378
Abstract

Tumor angiogenesis is regarded as a promising target for limiting cancer progression because tumor-associated vasculature supplies blood and provides a path for metastasis. Thus, in vitro recapitulation of vascularized tumors is critical to understand the pathology of cancer and identify the mechanisms by which tumor cells proliferate, metastasize, and respond to drugs. In this study, we microengineered a vascularized tumor spheroid (VTS) model to reproduce the pathological features of solid tumors. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Notably, the hybrid spheroids also exhibited expression profiles associated with aggressive behavior. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. With the VTS chip showing a progressive tumor phenotype, we validated the suppressive effects of axitinib on tumor growth and angiogenesis, which depended on exposure dose and time, highlighting the significance of tumor vascularization to predict the efficacy of anticancer drugs. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow. Thus, our VTS model is a valuable platform with which to investigate the interactions between tumor microenvironments and explore therapeutic strategies in cancer. STATEMENT OF SIGNIFICANCE: We conducted an integrative study within a vascularized tumor spheroid (VTS) model. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Through RNA sequencing, we elucidated that the tumor-EC hybrid spheroids exhibited expression profiles associated with aggressive behavior such as cancer progression, invasion and metastasis. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. We further validated the suppressive effects of axitinib on tumor growth and angiogenesis, depending on exposure dose and time. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow.

摘要

肿瘤血管生成被认为是限制癌症进展的一个有前途的靶点,因为肿瘤相关的脉管系统提供血液并为转移提供途径。因此,体外再现血管化肿瘤对于理解癌症的病理学并确定肿瘤细胞增殖、转移和对药物反应的机制至关重要。在这项研究中,我们微工程化了一个血管化肿瘤球体(VTS)模型,以再现实体瘤的病理特征。我们首先生成了具有自组装肿瘤内血管的肿瘤-EC 杂交球体,与仅由癌细胞组成的球体相比,这增强了球体的均匀性和肿瘤周围血管生成能力。值得注意的是,杂交球体还表现出与侵袭性行为相关的表达谱。在 VTS 芯片上围绕杂交球体长出的血管表现出渗漏性肿瘤血管的独特特征。随着 VTS 芯片显示出进行性肿瘤表型,我们验证了阿昔替尼对肿瘤生长和血管生成的抑制作用,这取决于暴露剂量和时间,突出了肿瘤血管生成对预测抗癌药物疗效的重要性。最终,我们通过促进间质流有效地诱导了肿瘤球体周围的淋巴管生成和血管生成。因此,我们的 VTS 模型是一个有价值的平台,可以研究肿瘤微环境之间的相互作用,并探索癌症的治疗策略。

意义陈述:我们在血管化肿瘤球体(VTS)模型中进行了综合研究。我们首先生成了具有自组装肿瘤内血管的肿瘤-EC 杂交球体,与仅由癌细胞组成的球体相比,这增强了球体的均匀性和肿瘤周围血管生成能力。通过 RNA 测序,我们阐明了肿瘤-EC 杂交球体表现出与侵袭性行为相关的表达谱,如癌症进展、侵袭和转移。在 VTS 芯片上围绕杂交球体长出的血管表现出渗漏性肿瘤血管的独特特征。我们进一步验证了阿昔替尼对肿瘤生长和血管生成的抑制作用,这取决于暴露剂量和时间。最终,我们通过促进间质流有效地诱导了肿瘤球体周围的淋巴管生成和血管生成。

相似文献

[1]
3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing.

Acta Biomater. 2023-7-15

[2]
Vascularized Lung Cancer Model for Evaluating the Promoted Transport of Anticancer Drugs and Immune Cells in an Engineered Tumor Microenvironment.

Adv Healthc Mater. 2022-6

[3]
Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo.

Tumour Biol. 2016-2

[4]
Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis.

Stem Cell Res Ther. 2024-8-26

[5]
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay.

Adv Healthc Mater. 2023-6

[6]
Enabling perfusion through multicellular tumor spheroids promoting lumenization in a vascularized cancer model.

Lab Chip. 2022-11-8

[7]
A Novel Ex Vivo Tumor Spheroid-Tissue Model for Investigating Microvascular Remodeling and Lymphatic Blood Vessel Plasticity.

Ann Biomed Eng. 2024-9

[8]
In vitro modeling of solid tumor interactions with perfused blood vessels.

Sci Rep. 2020-11-19

[9]
Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft.

Int J Mol Sci. 2021-7-31

[10]
Vascularized tumor-on-chip microplatforms for the studies of neovasculature as hope for more effective cancer treatments.

Biosens Bioelectron. 2024-4-1

引用本文的文献

[1]
Anti-angiogenic effects of silver nanoparticles on endothelial cells: in vitro and ex vivo studies.

Explor Target Antitumor Ther. 2025-7-27

[2]
Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer.

J Transl Med. 2025-7-16

[3]
Advances in human organs-on-chips and applications for drug screening and personalized medicine.

Fundam Res. 2024-2-22

[4]
Low-cost robotic manipulation of live microtissues for cancer drug testing.

Sci Adv. 2025-5-16

[5]
Microfluidic Modulation of Microvasculature in Microdissected Tumors.

bioRxiv. 2024-10-7

[6]
Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis.

Stem Cell Res Ther. 2024-8-26

[7]
3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer.

J Nanobiotechnology. 2024-6-18

[8]
A Novel Ex Vivo Tumor Spheroid-Tissue Model for Investigating Microvascular Remodeling and Lymphatic Blood Vessel Plasticity.

Ann Biomed Eng. 2024-9

[9]
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift.

Drug Deliv Transl Res. 2024-8

[10]
Spheroids formation in large drops suspended in superhydrophobic paper cones.

Biomicrofluidics. 2024-4-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索